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saturation of key themes (Figure 1). Reliability and validity of
coding were assessed (kappa >.90). Patients/caregivers re-
ported challenges in accessing specialty care due to providers’
unfamiliarity with HCT and felt SCP should be more person-
alized with robust sections on psychosocial, sexual/mental
health, and nutrition/diet. Providers wanted the treatment
history to focus only onwhat theymust know to care for their
patient and found SCP markedly better than what they
currently receive. All preferred to receive SCP electronically;
however, hardcopywas still considered necessary for patients
without computer access. Both patients and providers iden-
tiﬁed that SCPwill facilitate appropriate post-HCTcare. Similar
themes were identiﬁed among the three health professional
groups, with the exception of screening and care for psycho-
social issues that was more frequently brought up by the
nurses/social workers. Our study highlights the need for a SCP
instrument to facilitate HCT survivorship care. Patient and
provider feedback has been used to develop a ﬁnal SCP that is
being tested in a randomized trial.219
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Background: In advanced cancers, patients’ prognostic per-
ceptions inﬂuence their medical decisions. However, little is
known about how patients with hematologic malignancies
undergoing hematopoietic stem cell transplantation (HCT)
and their family caregivers (FC) understand their prognosis.
We examined prognostic perception in these patients during
hospitalization for HCT and its relationship with QOL and
mood.Figure 1A.Methods: We conducted a longitudinal study of patients
(and FC) hospitalized for HCT. At baseline (6 days pre-HCT),
we used a 10-item questionnaire to measure patients’ and FC
information preferences, and perception of prognosis. Using
2 items, we also asked the treating oncologists regarding the
patients’ prognosis. At day-6, day+1, day+8 of HCT, we
assessed QOL (Functional Assessment of Cancer Therapy-
Bone Marrow Transplantation FACT-BMT), and mood
(Hospital Anxiety and Depression Scale). We examined the
relationship between patients’ prognostic perception and
their QOL and mood during hospitalization for HCT using
multivariable linear mixed models.
Results: We enrolled 97% of consecutively eligible patients
undergoing autologous (n¼30), myeloablative (n¼30) or
reduced intensity (n¼30) allogeneic HCT. Most patients (80/
90, 88.9%) and FC (41/47, 87.1%) believed that it is “extremely”
or “very” important to know about prognosis [Figure 1A].
However, the majority of patients (66/85, 77.6%) and FC (33/
46, 71.7%) reported an inaccurate and more optimistic
perception of the patients’ prognosis compared to the
oncologist (P’s < 0.0001) [Figure 1B]. Patients with accurate
prognostic understanding reported lower QOL (P ¼ 0.03)
and worse depressive symptoms (P ¼ 0.04) with a steeper
increase in depression (P ¼ 0.006) over time compared to
patients with an inaccurate optimistic prognostic perception.
Conclusions: The majority of patients and FC reported
inaccurate and more optimistic perception of prognosis
compared with the oncologist. Patients with an accurate
perception of their prognosis had lower QOL, higher
depression, and a steeper increase in depression during
hospitalization for HCT. Interventions are needed to improve
prognostic understanding while providing adequate psy-
chosocial support during HCT.220
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Abstracts / Biol Blood Marrow Transplant 21 (2015) S171eS184S176Introduction: Studies suggest that among cancer patients
undergoing hematopoietic stem cell transplantation (HSCT),
low socioeconomic status (SES) is associated with worse
outcomes and higher mortality. Assessment of SES in these
studies has generally been limited to a single dimension such
as household income. We examined outcome after HSCT as a
function of ﬁnancial resources at the household and com-
munity level, and explored whether their association with
survival reﬂected educational disparities.
Method: 383 patients underwent allogeneic HSCT (57%
male; 82% White; mean age 50 y; 66% leukemia, 21% lym-
phoma). Pre-transplant, a social worker documented pa-
tients’ ﬁnancial resources and educational background. Via
census data, we derivedmedian household income and high-
school graduation rates at the census-block level. HSCT
outcomes over six years were obtained frommedical records.
Results: Controlling for demographics (age, gender, race,
marital status) and medical factors (disease, pre-transplant
chemotherapy, remission status, cell dose, donor-recipient
CMV status, donor sex), greater pre-transplant ﬁnancial re-
sources were associated with longer survival (HR 1.55;
p¼0.007), as was higher median neighborhood income (HR
1.52; p¼0.02). When entered simultaneously, higher ﬁnan-
cial resources (HR 1.45; p¼0.03) and neighborhood income
(HR 1.54, p¼0.06) continued to predict longer survival.
Adding educational attainment did not change the magni-
tude of these associations (ﬁnancial resources HR 1.60;
neighborhood income HR 1.90). Also, greater pre-transplant
ﬁnancial resources were associated with lower non-relapse
mortality (NRM) than lower resources (HR 0.45; p¼0.03).
Conclusions: Greater ﬁnancial resources are associated with
lower non-relapse mortality and higher 2-year overall sur-
vival post-HSCT. This association is independent of educa-
tional attainment, suggesting that it reﬂects the inﬂuence of
resources as opposed to knowledge or health literacy.221
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Infertility is one of the late effects in patients receiving he-
matopoietic stem cell transplantation (HSCT).The aim of this
study was to assess fertility in survivors following HSCT.
The study included 2698 HSCT survivors (aged>18) who
underwent transplantation between July 3, 1990 and August
30, 2014. The inclusion criterion for women entered the
study was the age of less than 50 years at the time of
transplantation. HSCT recipients (females and males) aged
over18 were determined eligible to participate in the study.
The study group consisted of 1714(63.5%) males and
984(36.5%) females withmean age of 31.5 years (range: 2-78)
at the time of HSCT. Median follow-up was 44 months
(1-286).
In this study, pregnancies occurred in female HSCT re-
cipients and in female partners of male recipients. There were
86 pregnancies (19 females and 67 males) following sponta-
neous conception (n¼54) and in vitro fertilization (ivF) treat-
ment with either their own eggs or donated eggs. The median
age of pregnancy in our participants was 31 years. Autologous
(n¼34), allogeneic (n¼50), and syngeneic (n¼2) hematopoi-
etic stem cells were primarily used in this study. AML (30%)
and HD (16.3%) were common diseases among pregnantwomen. The interval time between HST and fertility was 63
months.
Conclusion: The results of the survey showed that some
recipients are able to preserve their fertility following HSCT.
In order to increase the rate of pregnancies in HSCT survivors,
they should be informed about the impact of late effects of
HSCT on their fertility prior to treatment entry.
Keywords: Bone Marrow Transplantation, Fertility, Late
Effects.222
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Introduction: Patients diagnosed with cancer may experi-
ence psychological issues that can interfere with treatment
plans and adversely affect outcomes. Patients should be
screened for distress during pivotal medical visits. The
St. Louis University Blood and Marrow Transplant Program
(SLUBMT) began implementing the State Trait Anxiety In-
ventory (STAI) with patients duringmedical visits to evaluate
feelings of anxiety. Under normal conditions, average STAI
scores are: 35.72 (state)/34.89 (trait) for working, male
adults and 35.20 (state)/34.79 (trait) for working, female
adults. After implementing the STAI, it was realized that
these screenings could be analyzed in groups to determine if
patterns emerged regarding patients’ anxiety throughout the
bone marrow transplantation (BMT) process. The STAI has
been utilized in studies to determine the effectiveness of
interventions to decrease anxiety; however the study team is
unable to ﬁnd longitudinal studies which examine how STAI
scores are naturally affected over the course of the BMT
process.
Method: Institutional Review Board approval was received
to perform a retrospective examination of STAIs completed
by patients throughout the BMT process at the SLUBMT from
03/11/14 through 06/24/14. 30 inventories were collected,
de-identiﬁed, and categorized by the following medical
visits: arrival visit (ﬁrst visit to the clinic), data review visit
(visit to review transplant related testing and sign consents),
start of preparative regimen visit, day 0 visit, day +30 bone
marrow biopsy visit for allogenic transplantation, day +30
bonemarrow biopsy result visit for allogenic transplantation,
and day +100 visit for auto transplantation. Averages for each
category were determined by ﬁnding the mean score. Scores
were then compared to determine which medical visit(s)
caused patients to experience an increase in anxiety.
Results: Average scores were 46 (state)/38 (trait) during the
arrival visits, 41 (state)/45 (trait) during the data review
visits, and 44 (state)/39 (trait) during the start of preparative
regimen visits. During day 0 visits, patients’ scores decreased
to an average of 36 (state)/35 (trait). Day +30 and day +100
visits demonstrated even further decreases in anxiety scores.
Conclusion: Patients experience the highest levels of anxiety
during early medical visits of the BMT process. The sample
size was small and could possibly skew results. However, this
study does provide a starting basis for future study in BMT
recipient distress, andmulti-site studies are being planned to
ensure the accuracy of the patterns, which emerged from
this study. If patterns could be accurately predicted, the
study team may also be able to develop future studies to
preemptively lower patients’ anxiety levels early in the BMT
process and thus improve outcomes.
